These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 20480521

  • 1. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
    Buranrat B, Prawan A, Kukongviriyapan U, Kongpetch S, Kukongviriyapan V.
    World J Gastroenterol; 2010 May 21; 16(19):2362-70. PubMed ID: 20480521
    [Abstract] [Full Text] [Related]

  • 2. Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents.
    Zeekpudsa P, Kukongviriyapan V, Senggunprai L, Sripa B, Prawan A.
    J Exp Clin Cancer Res; 2014 Jan 24; 33(1):11. PubMed ID: 24460787
    [Abstract] [Full Text] [Related]

  • 3. Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cells.
    Prawan A, Buranrat B, Kukongviriyapan U, Sripa B, Kukongviriyapan V.
    J Cancer Res Clin Oncol; 2009 Apr 24; 135(4):515-22. PubMed ID: 18820947
    [Abstract] [Full Text] [Related]

  • 4. Phenethyl isothiocyanate induces calcium mobilization and mitochondrial cell death pathway in cholangiocarcinoma KKU-M214 cells.
    Tusskorn O, Senggunprai L, Prawan A, Kukongviriyapan U, Kukongviriyapan V.
    BMC Cancer; 2013 Dec 05; 13():571. PubMed ID: 24304591
    [Abstract] [Full Text] [Related]

  • 5. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
    Srijiwangsa P, Ponnikorn S, Na-Bangchang K.
    BMC Pharmacol Toxicol; 2018 Jun 19; 19(1):32. PubMed ID: 29914576
    [Abstract] [Full Text] [Related]

  • 6. Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner.
    Park EJ, Min KJ, Choi KS, Kwon TK.
    Exp Cell Res; 2014 Apr 15; 323(1):144-154. PubMed ID: 24462458
    [Abstract] [Full Text] [Related]

  • 7. β-Lapachone Induces Acute Oxidative Stress in Rat Primary Astrocyte Cultures that is Terminated by the NQO1-Inhibitor Dicoumarol.
    Steinmeier J, Kube S, Karger G, Ehrke E, Dringen R.
    Neurochem Res; 2020 Oct 15; 45(10):2442-2455. PubMed ID: 32789798
    [Abstract] [Full Text] [Related]

  • 8. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells.
    Khunluck T, Kukongviriyapan V, Senggunprai L, Duangarsong W, Prawan A.
    Integr Cancer Ther; 2019 Oct 15; 18():1534735418820444. PubMed ID: 30584780
    [Abstract] [Full Text] [Related]

  • 9. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
    Tepsiri N, Chaturat L, Sripa B, Namwat W, Wongkham S, Bhudhisawasdi V, Tassaneeyakul W.
    World J Gastroenterol; 2005 May 14; 11(18):2748-53. PubMed ID: 15884115
    [Abstract] [Full Text] [Related]

  • 10. Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells.
    Samatiwat P, Prawan A, Senggunprai L, Kukongviriyapan V.
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun 14; 388(6):601-12. PubMed ID: 25708948
    [Abstract] [Full Text] [Related]

  • 11. β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.
    Huang GL, Shen DY, Cai CF, Zhang QY, Ren HY, Chen QX.
    World J Gastroenterol; 2015 Jan 28; 21(4):1148-57. PubMed ID: 25632187
    [Abstract] [Full Text] [Related]

  • 12. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
    Buranrat B, Senggunprai L, Prawan A, Kukongviriyapan V.
    Life Sci; 2016 May 15; 153():41-9. PubMed ID: 27098189
    [Abstract] [Full Text] [Related]

  • 13. The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines.
    Choodetwattana P, Proungvitaya S, Jearanaikoon P, Limpaiboon T.
    Asian Pac J Cancer Prev; 2019 Sep 01; 20(9):2745-2748. PubMed ID: 31554372
    [Abstract] [Full Text] [Related]

  • 14. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
    Yothaisong S, Dokduang H, Techasen A, Namwat N, Yongvanit P, Bhudhisawasdi V, Puapairoj A, Riggins GJ, Loilome W.
    Tumour Biol; 2013 Dec 01; 34(6):3637-48. PubMed ID: 23832540
    [Abstract] [Full Text] [Related]

  • 15. Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
    Kongpetch S, Kukongviriyapan V, Prawan A, Senggunprai L, Kukongviriyapan U, Buranrat B.
    PLoS One; 2012 Dec 01; 7(4):e34994. PubMed ID: 22514698
    [Abstract] [Full Text] [Related]

  • 16. Distinct responses of compartmentalized glutathione redox potentials to pharmacologic quinones targeting NQO1.
    Kolossov VL, Ponnuraj N, Beaudoin JN, Leslie MT, Kenis PJ, Gaskins HR.
    Biochem Biophys Res Commun; 2017 Jan 29; 483(1):680-686. PubMed ID: 27986568
    [Abstract] [Full Text] [Related]

  • 17. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1.
    Asher G, Lotem J, Tsvetkov P, Reiss V, Sachs L, Shaul Y.
    Proc Natl Acad Sci U S A; 2003 Dec 09; 100(25):15065-70. PubMed ID: 14634213
    [Abstract] [Full Text] [Related]

  • 18. Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings.
    Sriraksa R, Limpaiboon T.
    Asian Pac J Cancer Prev; 2013 Dec 09; 14(4):2503-8. PubMed ID: 23725164
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
    Jaidee R, Kukongviriyapan V, Senggunprai L, Prawan A, Jusakul A, Laphanuwat P, Kongpetch S.
    Life Sci; 2022 May 01; 296():120427. PubMed ID: 35218764
    [Abstract] [Full Text] [Related]

  • 20. Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1).
    Megarity CF, Abdel-Aal Bettley H, Caraher MC, Scott KA, Whitehead RC, Jowitt TA, Gutierrez A, Bryce RA, Nolan KA, Stratford IJ, Timson DJ.
    Chembiochem; 2019 Nov 18; 20(22):2841-2849. PubMed ID: 31165578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.